ELEVANCE HEALTH, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3
ELEVANCE HEALTH, INC. (ELV) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 of $36.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-06.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 · last filed 2026-02-06
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2023-12-31 was $2.00M.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2023-09-30 was $2.00M, a 66.67% decline year-over-year.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2023-06-30 was $50.00M, a 92.31% increase year-over-year.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2023-03-31 was $1.00M.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2025 was $36.00M, a 50.00% increase from fiscal 2024.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2024 was $24.00M, a 9.09% increase from fiscal 2023.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2023 was $22.00M, a 15.79% increase from fiscal 2022.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2022 was $19.00M, a 280.00% increase from fiscal 2021.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 9 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $36.00M 10-K · filed 2026-02-06 | ||||||
| 2024-12-31 | $24.00M 10-K · filed 2026-02-06 | ||||||
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $4.00M derived: sum of 2 quarters · filed 2026-02-06 | $54.00M derived: sum of 3 quarters · filed 2026-02-06 | $22.00M 10-K · filed 2026-02-06 | |||
| 2023-09-30 | $2.00M 10-Q · filed 2023-10-18 | $52.00M derived: sum of 2 quarters · filed 2023-10-18 | $20.00M 10-Q · filed 2023-10-18 | $50.00M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-06-30 | $50.00M 10-Q/A · filed 2023-09-29 | $21.00M 10-Q/A · filed 2023-09-29 | $48.00M derived: sum of 3 quarters · filed 2025-02-20 | $54.00M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-03-31 | $1.00M 10-Q · filed 2023-04-19 | -$2.00M derived: sum of 2 quarters · filed 2025-02-20 | $4.00M derived: sum of 3 quarters · filed 2025-02-20 | $30.00M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2022-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $3.00M derived: sum of 2 quarters · filed 2025-02-20 | $29.00M derived: sum of 3 quarters · filed 2025-02-20 | $19.00M 10-K · filed 2025-02-20 | |||
| 2022-09-30 | $6.00M 10-Q · filed 2023-10-18 | $32.00M derived: sum of 2 quarters · filed 2023-10-18 | $22.00M 10-Q · filed 2023-10-18 | ||||
| 2022-06-30 | $26.00M 10-Q/A · filed 2023-09-29 | $21.00M 10-Q/A · filed 2023-09-29 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $10.00M derived: sum of 2 quarters · filed 2024-02-21 | $5.00M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $10.00M 10-Q · filed 2022-10-19 | $5.00M 10-Q · filed 2022-10-19 | |||||
| 2020-12-31 | $2.00M 10-Q · filed 2023-10-18 | ||||||
| 2020-06-30 | $0.00 10-Q · filed 2020-07-29 | $0.00 10-Q · filed 2020-07-29 | |||||
| 2019-12-31 | $210.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $210.00M derived: sum of 2 quarters · filed 2022-02-16 | $221.00M derived: sum of 3 quarters · filed 2022-02-16 | $230.00M 10-K · filed 2022-02-16 | |||
| 2019-09-30 | $0.00 10-Q · filed 2019-10-23 | $11.00M derived: sum of 2 quarters · filed 2020-07-29 | $20.00M 10-Q · filed 2020-10-28 | $20.00M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2019-06-30 | $11.00M 10-Q · filed 2020-07-29 | $20.00M 10-Q · filed 2020-07-29 | $20.00M derived: sum of 3 quarters · filed 2021-02-18 | $35.00M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2019-03-31 | $9.00M 10-Q · filed 2020-04-29 | $9.00M derived: sum of 2 quarters · filed 2021-02-18 | $24.00M derived: sum of 3 quarters · filed 2021-02-18 | $25.00M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $15.00M derived: sum of 2 quarters · filed 2021-02-18 | $16.00M derived: sum of 3 quarters · filed 2021-02-18 | $17.00M 10-K · filed 2021-02-18 | |||
| 2018-09-30 | $15.00M 10-Q · filed 2019-10-23 | $16.00M derived: sum of 2 quarters · filed 2019-10-23 | $17.00M 10-Q · filed 2019-10-23 | $22.00M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-06-30 | $1.00M 10-Q · filed 2019-07-24 | $600.00K 10-Q · filed 2018-07-25 | $2.00M 10-Q · filed 2019-07-24 | $7.00M derived: sum of 3 quarters · filed 2020-02-19 | $35.00M derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2018-03-31 | $1.00M 10-Q · filed 2019-04-24 | $1.40M 10-Q · filed 2018-04-25 | $6.00M derived: sum of 2 quarters · filed 2020-02-19 | $34.00M derived: sum of 3 quarters · filed 2020-02-19 | $49.20M derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2017-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $33.00M derived: sum of 2 quarters · filed 2020-02-19 | $48.20M derived: sum of 3 quarters · filed 2020-02-19 | $79.00M 10-K · filed 2020-02-19 | $78.60M 10-K · filed 2018-02-21 | ||
| 2017-09-30 | $28.00M 10-Q · filed 2018-10-31 | $27.80M 10-Q · filed 2017-10-25 | $43.20M derived: sum of 2 quarters · filed 2018-10-31 | $74.00M 10-Q · filed 2018-10-31 | $74.20M 10-Q · filed 2017-10-25 | $86.30M derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-06-30 | $15.20M 10-Q · filed 2018-07-25 | $46.40M 10-Q · filed 2018-07-25 | $58.30M derived: sum of 3 quarters · filed 2019-02-20 | $58.30M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-03-31 | $31.20M 10-Q · filed 2018-04-25 | $43.10M derived: sum of 2 quarters · filed 2019-02-20 | $43.10M derived: sum of 3 quarters · filed 2019-02-20 | $100.30M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2016-12-31 | $11.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $11.90M derived: sum of 2 quarters · filed 2019-02-20 | $69.10M derived: sum of 3 quarters · filed 2019-02-20 | $71.00M 10-K · filed 2019-02-20 | $70.80M 10-K · filed 2017-02-22 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-10-25 | $57.20M derived: sum of 2 quarters · filed 2017-10-25 | $59.10M 10-Q · filed 2017-10-25 | $65.20M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-06-30 | $57.20M 10-Q · filed 2017-07-26 | $59.10M 10-Q · filed 2017-07-26 | $65.20M derived: sum of 3 quarters · filed 2018-02-21 | $79.20M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-03-31 | $1.90M 10-Q · filed 2017-04-26 | $8.00M derived: sum of 2 quarters · filed 2018-02-21 | $22.00M derived: sum of 3 quarters · filed 2018-02-21 | $41.70M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2015-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $20.10M derived: sum of 2 quarters · filed 2018-02-21 | $39.80M derived: sum of 3 quarters · filed 2018-02-21 | $42.80M 10-K · filed 2018-02-21 | |||
| 2015-09-30 | $14.00M 10-Q · filed 2016-11-02 | $33.70M derived: sum of 2 quarters · filed 2016-11-02 | $36.70M 10-Q · filed 2016-11-02 | $40.10M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-06-30 | $19.70M 10-Q · filed 2016-07-27 | $22.70M 10-Q · filed 2016-07-27 | $26.10M derived: sum of 3 quarters · filed 2017-02-22 | $37.20M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-03-31 | $3.00M 10-Q · filed 2016-04-27 | $6.40M derived: sum of 2 quarters · filed 2017-02-22 | $17.50M derived: sum of 3 quarters · filed 2017-02-22 | $20.60M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $14.50M derived: sum of 2 quarters · filed 2017-02-22 | $17.60M derived: sum of 3 quarters · filed 2017-02-22 | $24.10M 10-K · filed 2017-02-22 | |||
| 2014-09-30 | $11.10M 10-Q · filed 2015-10-28 | $14.20M derived: sum of 2 quarters · filed 2015-10-28 | $20.70M 10-Q · filed 2015-10-28 | $20.70M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-06-30 | $3.10M 10-Q · filed 2015-07-29 | $9.60M 10-Q · filed 2015-07-29 | $9.60M derived: sum of 3 quarters · filed 2016-02-19 | $22.50M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-03-31 | $6.50M 10-Q · filed 2015-04-29 | $6.50M derived: sum of 2 quarters · filed 2016-02-19 | $19.40M derived: sum of 3 quarters · filed 2016-02-19 | $26.10M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $12.90M derived: sum of 2 quarters · filed 2016-02-19 | $19.60M derived: sum of 3 quarters · filed 2016-02-19 | $22.50M 10-K · filed 2016-02-19 | |||
| 2013-09-30 | $12.90M 10-Q · filed 2014-10-29 | $19.60M derived: sum of 2 quarters · filed 2014-10-29 | $22.50M 10-Q · filed 2014-10-29 | $27.80M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-06-30 | $6.70M 10-Q · filed 2014-07-30 | $9.60M 10-Q · filed 2013-07-24 | $14.90M derived: sum of 3 quarters · filed 2015-02-24 | $20.70M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | $2.90M 10-Q · filed 2014-04-30 | $8.20M derived: sum of 2 quarters · filed 2015-02-24 | $14.00M derived: sum of 3 quarters · filed 2015-02-24 | $14.00M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $11.10M derived: sum of 2 quarters · filed 2015-02-24 | $11.10M derived: sum of 3 quarters · filed 2015-02-24 | $116.80M 10-K · filed 2015-02-24 | -$116.80M 10-K · filed 2013-02-22 | ||
| 2012-09-30 | $5.80M 10-Q · filed 2013-10-23 | $5.80M derived: sum of 2 quarters · filed 2013-10-23 | $111.50M 10-Q · filed 2013-10-23 | $118.10M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2012-06-30 | $0.00 10-Q · filed 2013-07-24 | $105.70M 10-Q · filed 2013-07-24 | $112.30M derived: sum of 3 quarters · filed 2014-02-20 | $112.30M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2012-03-31 | $105.70M 10-Q · filed 2013-04-24 | $112.30M derived: sum of 2 quarters · filed 2014-02-20 | $112.30M derived: sum of 3 quarters · filed 2014-02-20 | $112.30M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2011-12-31 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $6.60M derived: sum of 2 quarters · filed 2014-02-20 | $6.60M derived: sum of 3 quarters · filed 2014-02-20 | $6.60M 10-K · filed 2014-02-20 | |||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-07 | $0.00 derived: sum of 2 quarters · filed 2012-11-07 | $0.00 10-Q · filed 2012-11-07 | ||||
| 2011-06-30 | $0.00 10-Q · filed 2012-07-25 | $0.00 10-Q · filed 2012-07-25 | |||||
| 2011-03-31 | $0.00 10-Q · filed 2012-04-25 | ||||||
| 2010-12-31 | $0.00 10-K · filed 2013-02-22 | ||||||
| 2009-12-31 | $26.00M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |